| Gene symbol | ROR1 | Synonyms | NTRKR1, dJ537F10.1 | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1p31.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | receptor tyrosine kinase like orphan receptor 1 | ||||
| GTO ID | GTC3102 |
| Trial ID | NCT05444322 |
| Disease | Diffuse Large B-Cell Lymphoma | Mantle Cell Lymphoma | Follicular Lymphoma |
| Altered gene | ROR1 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | RD14-01 |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | A Study of RD14-01 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma |
| Year | 2022 |
| Country | China |
| Company sponsor | He Huang |
| Other ID(s) | BHCT-RD14-01 |
| Cohort 1 | |||||||||
|
|||||||||